<DOC>
	<DOCNO>NCT00000661</DOCNO>
	<brief_summary>To determine pharmacokinetic ( blood level ) interaction exist zidovudine ( AZT ) oxazepam HIV-infected patient . Benzodiazepines ( oxazepam ) among frequently prescribe class drug commonly use therapeutically patient chronic disease . This study important potential toxicity result reaction AZT benzodiazepine likelihood frequent use combination drug patient HIV infection .</brief_summary>
	<brief_title>The Pharmacokinetics Zidovudine Oxazepam Alone Combination HIV-Infected Patient</brief_title>
	<detailed_description>Benzodiazepines ( oxazepam ) among frequently prescribe class drug commonly use therapeutically patient chronic disease . This study important potential toxicity result reaction AZT benzodiazepine likelihood frequent use combination drug patient HIV infection . Patients studied determine oral intravenous AZT single oral dose oxazepam pharmacokinetics . Patients take AZT oxazepam together determine interaction drug occur .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Oxazepam</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Required : Stable prescribed dosage zidovudine ( AZT ) , = &gt; 500 mg/day . Allowed : Prophylaxis Pneumocystis carinii pneumonia ( PCP ) aerosolize pentamidine . Erythropoietin . Patients must : HIV positive ELISA Western blot . Currently take stable prescribe dosage 500 mg/day zidovudine ( AZT ) . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Allergy benzodiazepines previously document intolerance zidovudine ( AZT ) therapy = &lt; 600 mg/day . Significant underlying medical condition could impair continuous participation study . Malabsorption syndrome ( 3 loose stool day least 4 week associate unintentional weight loss least 10 percent body weight ) . Concurrent Medication : Excluded : Oral contraceptive . Cytotoxic chemotherapy . Ganciclovir . Flucytosine . Probenecid . Opiates . Valproic acid . Sulfa drug . Sucralfate . Dapsone . Rifampin . Antacids within 2 hour zidovudine ( AZT ) dose . Isoniazid . Ketoconazole . Pyrimethamine . Clindamycin . Aspirin . Ibuprofen . Investigational drug specifically allow . Patients follow exclude : Allergy benzodiazepines previously document intolerance zidovudine ( AZT ) therapy = &lt; 600 mg/day . Significant underlying medical condition could impair continuous participation study . Unable take oral medication reliably . Prior Medication : Excluded within 30 day study entry : Antiretroviral agent zidovudine ( AZT ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1994</verification_date>
	<keyword>Oxazepam</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Zidovudine</keyword>
</DOC>